Quick Answer
Bioventus Inc. reported Long-Term Debt of $278.95 million for fiscal year 2025.
Bioventus Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $278.95M | -9.5% |
| 2024 | $308.29M | -16.0% |
| 2023 | $367.00M | -4.7% |
| 2022 | $385.01M | +13.4% |
| 2021 | $339.64M | +95.9% |
| 2020 | $173.38M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $311.33M | -9.8% | +4.5% |
| June 30, 2025 | $297.88M | -13.6% | -3.5% |
| March 31, 2025 | $308.59M | -13.2% | +0.1% |
| December 31, 2024 | $308.29M | -16.0% | -10.6% |
| September 30, 2024 | $345.02M | -8.0% | +0.1% |
| June 30, 2024 | $344.72M | -8.0% | -3.0% |
| March 31, 2024 | $355.43M | -12.1% | -3.2% |
| December 31, 2023 | $367.00M | -4.7% | -2.1% |
- Bioventus Inc. showed a decrease of -9.5% in Long-Term Debt compared to the prior fiscal year.
- Over the 2020–2025 period, Bioventus Inc.’s long-term debt has grown by 60.9% (from $173.38 million to $278.95 million).
- The most recent figure is from Bioventus Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: